Brazilian lung cancer care under the microscope: are doctors following the rules?

NCT ID NCT07109154

Recruiting now Knowledge-focused Sponsor: AstraZeneca Source: ClinicalTrials.gov ↗

Summary

This study aims to understand how doctors in Brazil treat patients with advanced non-small cell lung cancer (NSCLC) in real-world settings. Researchers will collect medical record data from 200 patients starting first-line treatment between 2025-2026 and survey about 300 oncologists about their treatment decisions. The goal is to see if real-world treatment choices match national guidelines and identify factors influencing doctors' decisions.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LUNG NEOPLASMS are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Research Site
ACTIVE_NOT_RECRUITING

Recife, Brazil
Research Site
RECRUITING

Rio de Janeiro, Brazil
Research Site
NOT_YET_RECRUITING

Rio de Janeiro, Brazil
Research Site
RECRUITING

Salvador, Brazil
Research Site
NOT_YET_RECRUITING

Salvador, Brazil
Research Site
ACTIVE_NOT_RECRUITING

São Paulo, Brazil
Research Site
NOT_YET_RECRUITING

São Paulo, Brazil

Conditions

Explore the condition pages connected to this study.

LUNG NEOPLASMS